Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer

Published:2017-01 Issue:1 Volume:97 Page:146-154
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Verma Vivek,McMillan Matthew T.,Grover Surbhi,Simone Charles B.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. National Comprehensive Cancer Network. Non-small cell lung cancer. Version 4.2016. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. Accessed May 30, 2016.

2. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

3. Stereotactic body radiation therapy for lung cancer;Simone;Chest,2013

4. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials;Chang;Lancet Oncol,2015

5. Stereotactic radiotherapy versus surgery for early-stage operable lung cancer: More questions than answers;Verma;J Natl Compr Canc Netw,2015

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation;Radiotherapy and Oncology;2024-01

2. Research Progress of Radiotherapy Combined with Immunotherapy in Non-Small Cell Lung Cancer;Journal of Clinical Personalized Medicine;2024

3. Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer – A Phase I Dose Escalation Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

4. Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-09

5. Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm;Clinical Lung Cancer;2023-01